Next Article in Journal
Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins
Next Article in Special Issue
Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies
Previous Article in Journal
Quality Assessment of Platelet-Rich Fibrin-Like Matrix Prepared from Whole Blood Samples after Extended Storage
Open AccessReview

Innovative Disease Model: Zebrafish as an In Vivo Platform for Intestinal Disorder and Tumors

Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore 117543, Singapore
School of Pharmacy, National Defense Medical Center, No. 161, Section 6, Minquan East Road, Taipei 114, Taiwan
Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, No. 1 Chang-Te Street, Taipei 100, Taiwan
Authors to whom correspondence should be addressed.
Biomedicines 2017, 5(4), 58;
Received: 13 September 2017 / Revised: 26 September 2017 / Accepted: 29 September 2017 / Published: 29 September 2017
(This article belongs to the Special Issue Cancer Biomarkers and Targets in Digestive Organs)
Colorectal cancer (CRC) is one of the world’s most common cancers and is the second leading cause of cancer deaths, causing more than 50,000 estimated deaths each year. Several risk factors are highly associated with CRC, including being overweight, eating a diet high in red meat and over-processed meat, having a history of inflammatory bowel disease, and smoking. Previous zebrafish studies have demonstrated that multiple oncogenes and tumor suppressor genes can be regulated through genetic or epigenetic alterations. Zebrafish research has also revealed that the activation of carcinogenesis-associated signal pathways plays an important role in CRC. The biology of cancer, intestinal disorders caused by carcinogens, and the morphological patterns of tumors have been found to be highly similar between zebrafish and humans. Therefore, the zebrafish has become an important animal model for translational medical research. Several zebrafish models have been developed to elucidate the characteristics of gastrointestinal diseases. This review article focuses on zebrafish models that have been used to study human intestinal disorders and tumors, including models involving mutant and transgenic fish. We also report on xenograft models and chemically-induced enterocolitis. This review demonstrates that excellent zebrafish models can provide novel insights into the pathogenesis of gastrointestinal diseases and help facilitate the evaluation of novel anti-tumor drugs. View Full-Text
Keywords: colorectal cancer; intestinal disorder; intestinal tumors; zebrafish colorectal cancer; intestinal disorder; intestinal tumors; zebrafish
Show Figures

Graphical abstract

MDPI and ACS Style

Lu, J.-W.; Ho, Y.-J.; Ciou, S.-C.; Gong, Z. Innovative Disease Model: Zebrafish as an In Vivo Platform for Intestinal Disorder and Tumors. Biomedicines 2017, 5, 58.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop